Effects of androsterone on convulsions in various seizure models in mice.

It is believed that a deficiency of androgens, including free testosterone, may promote the development of convulsions. The present study revealed differences in the action of androsterone (AND), a major excreted metabolite of testosterone and a neurosteroid, in three commonly used seizure models in mice. AND administered intraperitoneally exhibited dose-dependent protection against tonic-clonic convulsions caused by maximal electroshock (MES) with ED(50) (effective dose(50)) of 227 mg/kg. The compound also inhibited the convulsive action of pentylenetetrazole (PTZ), increasing its CD(50) (convulsive dose(50)) for clonic convulsions from 77.2 (PTZ + saline) to 93.9 (p < 0.05) for PTZ + AND 40 mg/kg and 113.9 mg/kg (p < 0.001) for PTZ + AND 60 mg/kg. In mice pretreated with 60 mg/kg AND, the CD(50) for PTZ-induced tonic convulsions increased from 102 to 127.6 mg/kg (p < 0.01). Surprisingly, doses of 50 and 100 mg/kg AND lowered the CD(50) for kainate (KA)-induced convulsions from 40.8 to 28.7 (p < 0.05) and 25.4 mg/kg (p < 0.001), respectively. In summary, for two of the mouse seizure models, our findings confirmed previous studies that demonstrated protective activity of AND. However, the potentiation of KA-induced convulsions by AND was somewhat unexpected and suggested that AND may also possess proconvulsant activity.
AuthorsKatarzyna Mróz, Tomasz Mróz, Marian Wielosz, Piotr Tutka
JournalPharmacological reports : PR (Pharmacol Rep) 2009 May-Jun Vol. 61 Issue 3 Pg. 564-9 ISSN: 1734-1140 [Print] Poland
PMID19605957 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Androsterone
  • Kainic Acid
  • Pentylenetetrazole
  • Androsterone (therapeutic use)
  • Animals
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Electroshock (methods)
  • Kainic Acid (agonists)
  • Male
  • Mice
  • Pentylenetetrazole (antagonists & inhibitors)
  • Seizures (chemically induced, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: